Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata had lower vitamin D levels, but these levels did not relate to how severe their condition was.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

Topical ruxolitinib failed to regrow hair in a 66-year-old with alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Early onset, severe types, nail changes, family history, and body hair loss worsen alopecia areata prognosis; sticking to treatment helps.

Tofacitinib is effective for treating alopecia areata, and starting treatment early may improve results.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

People with Alopecia areata often have lower Vitamin D levels, which might affect the severity of their condition.

Mesalazine may help treat extensive alopecia areata effectively.

Too much epidermal growth factor can cause hair loss.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Microneedling with betamethasone led to almost complete hair regrowth in severe alopecia areata.

Both platelet-rich plasma and low-level laser therapy effectively treat hair loss with minimal side effects and good cost-benefit ratio.

Alopecia areata is an autoimmune disease with genetic links, treatable with certain medications, and can affect mental health.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

New understanding and treatments for hair loss are improving, but more research is needed.

A patient with complete hair loss regrew all her hair using tofacitinib.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Minoxidil and spironolactone combo effectively treats androgenetic alopecia, improving hair density and diameter.

Early diagnosis and personalized treatments are crucial for better hair loss management.

Oral alitretinoin can quickly regrow hair in alopecia universalis.